1.Fu Y, Xu M, Cui Z, Yang Z, Zhang Z, Yin X, Huang X, Zhou M, Wang X, Chen C. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia. EBioMedicine. 2020 Feb;52:102664.
2.Yang Z, Yan G, Zheng L, Gu W, Liu F, Chen W, Cui X, Wang Y, Yang Y, Chen X,Fu Y#, Xu X#. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration. Oncoimmunology. 2021 Jun 23;10(1):1938890.
3.Liu F, Yang Z, Zheng L, Shao W, Cui X, Wang Y, Jia J,Fu Y. A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer. Front Oncol. 2021 Jun 14;11:690129.
4.Fu Y, Yang Y, Wang X, Yin X, Zhou M, Wang S, Yang L, Huang T, Xu M, Chen C. The histone demethylase PHF8 promotes adult acute lymphoblastic leukemia through interaction with the MEK/ERK signaling pathway. Biochem Biophys Res Commun. 2018 Feb 12;496(3):981-987.
5.Yu L, Yang Z, Liu Y, Liu F, Shang W, Shao W, Wang Y, Xu M, Wang YN,Fu Y#, Xu X#. Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses. PeerJ. 2020 Jun 17;8:e9393.
